Guided Creeping Technique (GCT) in Treating Gingival Recession

Guided Creeping Technique (GCT) as a Novel Minimally Invasive Approach in Treating Gingival Recession - Single Arm Preliminary Study

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05101642

Enrollment

Registered

2021-11-01

Start date

2021-09-15

Completion date

2022-06-30

Last updated

2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingival Recession

Keywords

Minimally Invasive Surgery, Tunneling Techniques, Gingival Recession, Creeping Attachment

Brief summary

A novel minimally invasive guided creeping technique (GCT) is suggested to treat gingival recessions.

Detailed description

Background: Coronally advanced flap with connective tissue grafting in a conventional or minimally invasive approaches includes massive soft tissue reflection that reduce soft tissue support and compromise vascularity around the grafted material. In an attempt to preserve soft tissue support, graft stability and maximizing graft protection in treating recession defects the present novel minimally invasive guided creeping technique (GCT) is suggested. Methods: Twelve patients, each contributing a single Cairo RT1 GR defect, were treated by guided creeping technique and completed the 6 months follow up. Clinical, evaluations were performed and differences among groups were analyzed.

Interventions

PROCEDUREGuided Creeping Technique (GCT)

Guided Creeping Technique (GCT) is a novel minimally invasive blind tunnel

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 50 Years

Healthy volunteers

Yes

Inclusion criteria

* Over 18 years of age * Systemically and periodontally healthy * Presence of isolated buccal Cairo RT1 gingival recessions * An identifiable CEJ * Affected teeth with at least 2mm attached gingiva.

Exclusion criteria

* Smokers * Pregnancy * Using antiepileptic drugs * Using antibiotics for at least 20 days before surgery

Design outcomes

Primary

Measure	Time frame	Description
Recession Coverage	Change from baseline to 6 months	Measured in mm

Secondary

Measure	Time frame	Description
Keratinized Tissue Width	Change from baseline to 6 months	Measured in mm
Keratinized Tissue Thickness	Change from baseline to 6 months	Measured in mm

Other

Measure	Time frame	Description
Patient Reported Outcome	Through 14 days	Visual Analog Scale (VAS)

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026